Weight Loss Drug Like Ozempic Could Be the World’s First Trillion-Dollar Drug
The FDA is on the cusp of an announcement that could create the first trillion-dollar drug — out of GPL-1 class drugs like Ozempic.
Posted by Ian King | Jul 2, 2024 | Banyan Edge, Diversified Investments, Investment Opportunities, Technology
The FDA is on the cusp of an announcement that could create the first trillion-dollar drug — out of GPL-1 class drugs like Ozempic.
Posted by Aaron James | Nov 26, 2023 | Banyan Edge, Investing, Investment Opportunities
“Miracle drugs” are trending again. Are new weight loss drugs like Wegovy and Ozempic going to create big profits from big losses?
Posted by Adam O'Dell | Nov 17, 2023 | Banyan Edge, Diversified Investments, Trending
From Chealsea Handler to Elon Musk, Novo Nordisk’s Ozempic has been hailed a “miracle drug.” Is it worth investing in?
Subscribe to our Banyan Edge newsletter to get financial insights and tips from our top investment experts. Start investing with an edge today!
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor
Chief Investment Strategist of Money & Markets
Research Analyst
Director of VIP Services
“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”
- David G. (Member since 2018)
“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”
- Larry K.
"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"
- Keith S.